Browsing Archives by Subject "matinib Mesylate Therapy Among Chronic Myeloid Leukaemia Patients"
Now showing items 1-1 of 1
-
Evaluation Of Response To Imatinib Mesylate Therapy Among Chronic Myeloid Leukaemia Patients As Seen In Nairobi, Kenya
(University of Nairobi, 2018)Background: Without treatment, chronic myeloid leukemia (CML) progresses from a chronic phase (CP) followed by an accelerated phase (AP) and then to the blast phase (BP).The approval of imatinib mesylate by the Food and ...